National News

50 million doses of Covaxin set to expire in early 2023 due to poor demand

By Odisha News Online Nov 6, 2022 233

HYDERABAD, NOV 6: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech […]Continue Reading

National News

DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group

By Odisha News Online Apr 26, 2022 448

New Delhi, April 26: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, Union Health Minister Mansukh Mandaviya said on Tuesday. The Drugs Controller General of India (DCGI) […]Continue Reading

Odisha News

କୋଭିସିଲ୍ଡ ଓ କୋଭାକ୍ସିନ ବୁଷ୍ଟର ଡୋଜର ମୂଲ୍ୟ ହ୍ରାସ

By Odisha News Online Apr 9, 2022 237

ନୂଆଦିଲ୍ଲୀ, ୯/୪: କେନ୍ଦ୍ର ସ୍ୱାସ୍ଥ୍ୟ ମନ୍ତ୍ରାଳୟ ଘରୋଇ ଟିକାକରଣ କେନ୍ଦ୍ରରେ ୧୮ ବର୍ଷରୁ ଅଧିକ ବର୍ଗଙ୍କ ପାଇଁ କୋଭିଡ-୧୯ ଟିକାର ସତର୍କତାମୂଳକ ତୃତୀୟ ଡୋଜ୍ ବା ବୁଷ୍ଟର ଡୋଜ୍ ରୋଲଆଉଟ୍ ଘୋଷଣା କରିବାର ଗୋଟିଏ ଦିନ ପରେ ଟିକା ମୂଲ୍ୟ ହ୍ରାସ କରିଛନ୍ତି ସେରମ ଇନଷ୍ଟିଚ୍ୟୁଟ୍ ଓ ଭାରତ ବାୟୋଟେକ୍।ଗତକାଲି କୋଭିସିଲ୍ଟ ଟିକା ଟ୍ୟାକ୍ସକୁ ଛାଡ଼ି ୬୦୦ ଟଙ୍କାରେ ଉପଲବ୍ଧ ହେବ ବୋଲି କହିଥିଲେ ସେରମ ଇନଷ୍ଟିଚ୍ୟୁଟର ମୁଖ୍ୟ ଅଦାର ପୁନାୱାଲା।ପରିବର୍ତ୍ତନ ଅଣାଯାଇ Continue Reading

Top Stories

WHO suspends Covaxin supply to UN agencies

By Odisha News Online Apr 3, 2022 293

Hyderabad.April 3 : The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the […]Continue Reading

National News

Two COVID vaccines may cost Rs. 275 after market nod

By Odisha News Online Jan 27, 2022 285

NEW DELHI, JAN 27 : In a bid to make vaccines against Covid-19 affordable, prices of Covishield and Covaxin jabs are likely to be capped at Rs 275 per dose, with an additional service charge of Rs 150. A regular market approval is awaited for both the vaccines from India’s drug regulator, the Drugs Controller […]Continue Reading

National News

SEC approval for Bharat Biotech’s COVID booster intranasal vaccine phase 3 trials

By Odisha News Online Jan 5, 2022 324

New Delhi, JAN 5: The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who have taken both the doses of Covaxin and Covishield. The SEC has asked the […]Continue Reading

National News

AIIMS to begin COVID vaccine human trial from next neek

By Odisha News Online Jul 19, 2020 535

New Delhi, July 19 : In a major development, AIIMS Delhi will begin human trials of India’s first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in […]Continue Reading